News · Cell Therapy
309 stories
Sep 9, 26CEO O’Day tells Fierce how Gilead’s cancer, inflammation expansion has reached ‘critical mass’
Sep 9, 26Novo’s canned heart disease trials, Novartis’ clinical fails, first approval for Alexander disease
309 stories